Schroder Investment Management Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-195,307
| Closed | -$8.23M | – | 1260 |
|
|
2023
Q2 | $8.23M | Sell |
195,307
-347,287
| -64% | -$14M | 0.01% | 679 |
|
|
2023
Q1 | $19.3M | Sell |
542,594
-122,742
| -18% | -$4.45M | 0.03% | 479 |
|
|
2022
Q4 | $24.4M | Buy |
665,336
+111,568
| +20% | +$4.41M | 0.04% | 407 |
|
|
2022
Q3 | $26.1M | Buy |
553,768
+35,621
| +7% | +$2.3M | 0.04% | 377 |
|
|
2022
Q2 | $37.4M | Buy |
518,147
+16,143
| +3% | +$1.18M | 0.06% | 318 |
|
|
2022
Q1 | $41M | Sell |
502,004
-145,262
| -22% | -$12.3M | 0.05% | 330 |
|
|
2021
Q4 | $66.5M | Sell |
647,266
-11,300
| -2% | -$1.09M | 0.09% | 232 |
|
|
2021
Q3 | $57.6M | Sell |
658,566
-101,458
| -13% | -$9.18M | 0.09% | 241 |
|
|
2021
Q2 | $68M | Buy |
760,024
+25,382
| +3% | +$2.14M | 0.09% | 236 |
|
|
2021
Q1 | $55.7M | Buy |
734,642
+207,211
| +39% | +$15.6M | 0.07% | 280 |
|
|
2020
Q4 | $35.9M | Buy |
527,431
+147,987
| +39% | +$9.23M | 0.05% | 338 |
|
|
2020
Q3 | $21.2M | Buy |
379,444
+7,021
| +2% | +$418K | 0.03% | 424 |
|
|
2020
Q2 | $21.7M | Sell |
372,423
-11,423
| -3% | -$614K | 0.04% | 401 |
|
|
2020
Q1 | $15.7M | Sell |
383,846
-119,905
| -24% | -$7.01M | 0.03% | 427 |
|
|
2019
Q4 | $30M | Buy |
503,751
+3,479
| +0.7% | +$187K | 0.05% | 401 |
|
|
2019
Q3 | $26.5M | Sell |
500,272
-40,644
| -8% | -$2.09M | 0.05% | 401 |
|
|
2019
Q2 | $27.6M | Buy |
540,916
+15,675
| +3% | +$730K | 0.05% | 377 |
|
|
2019
Q1 | $27.2M | Sell |
525,241
-83,479
| -14% | -$4.05M | 0.05% | 398 |
|
|
2018
Q4 | $24K | Buy |
608,720
+34,964
| +6% | +$1.62M | 0.04% | 393 |
|
|
2018
Q3 | $29.6M | Buy |
573,756
+117,751
| +26% | +$5.77M | 0.05% | 389 |
|
|
2018
Q2 | $21.4M | Sell |
456,005
-130,103
| -22% | -$5.39M | 0.04% | 445 |
|
|
2018
Q1 | $20.8M | Buy |
586,108
+49,588
| +9% | +$1.94M | 0.04% | 450 |
|
|
2017
Q4 | $23.4M | Buy |
536,520
+175,713
| +49% | +$8.21M | 0.04% | 474 |
|
|
2017
Q3 | $19M | Sell |
360,807
-9,751
| -3% | -$544K | 0.03% | 493 |
|
|
2017
Q2 | $21.6M | Buy |
370,558
+1,653
| +0.4% | +$85.9K | 0.04% | 454 |
|
|
2017
Q1 | $16.7M | Buy |
368,905
+28,384
| +8% | +$1.41M | 0.03% | 518 |
|
|
2016
Q4 | $17.9M | Buy |
340,521
+5,321
| +2% | +$258K | 0.03% | 516 |
|
|
2016
Q3 | $14.9M | Sell |
335,200
-1,700
| -0.5% | -$73.7K | 0.03% | 535 |
|
|
2016
Q2 | $12.8M | Sell |
336,900
-79,700
| -19% | -$3.5M | 0.03% | 565 |
|
|
2016
Q1 | $16.9M | Sell |
416,600
-6,000
| -1% | -$247K | 0.04% | 509 |
|
|
2015
Q4 | $20.5M | Sell |
422,600
-93,600
| -18% | -$4.16M | 0.04% | 457 |
|
|
2015
Q3 | $20.6M | Sell |
516,200
-27,500
| -5% | -$1.2M | 0.04% | 453 |
|
|
2015
Q2 | $20.7M | Buy |
543,700
+288,800
| +113% | +$9.96M | 0.04% | 458 |
|
|
2015
Q1 | $8.14M | Buy |
254,900
+4,900
| +2% | +$135K | 0.02% | 689 |
|
|
2014
Q4 | $6.42M | Buy |
+250,000
| New | +$5.95M | 0.01% | 742 |
|
Other funds holding SYNH
IA
BTI
CFB
HNB
Schroder Investment Management Group's SYNH Position: Q3 2023 in Review
Schroder Investment Management Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 195,307 shares — an estimated $8.23M sold.
Schroder Investment Management Group first reported a position in SYNH in Q4 2014 and held it in 35 quarters. The position peaked at $68M in Q2 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.
- Schroder Investment Management Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- Schroder Investment Management Group sold 195,307 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $8.23M.
- Schroder Investment Management Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 35 quarters.
- Schroder Investment Management Group's Syneos Health, Inc. Class A Common Stock position peaked at $68M in Q2 2021.
- 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.
Based on Schroder Investment Management Group's 13F filing for Q3 2023, filed 14 Nov 2023.